[DEPARTMENT PERSONNEL ORDER NO. 2021-3184] APPOINTMENT OF THE NEW MEMBER OF THE HEALTH TECHNOLOGY ASSESSMENT COUNCIL SUBCOMMITTEE ON PREVENTIVE AND PROMOTIVE HEALTH

preliminary recommendation for the inclusion of sambong 250mg tablets as anti-urolithiasis

PRELIMINARY RECOMMENDATION ON Emtricitabine + Tenofovir Disoproxil Fumarate fixed-dose combination as Oral Pre-Exposure Prophylaxis (PrEP)

[DEPARTMENT PERSONNEL ORDER NO. 2021-2780] CREATION OF POOL OF CLINICAL EXPERTS FOR CONSULTATION ON THE Evaluation of assessment topics

[DEPARTMENT CIRCULAR NO. 2021- 0471] Nomination to the Health Technology Assessment Council (HTAC) Subcommittee on Preventive and Promotive Health

[DEPARTMENT CIRCULAR NO. 2021- 0468] Health Technology Assessment Council (HTAC) Recommendations on COVID-19 Vaccination of the Pediatric Population

[Signed by Secretary of Health] HTAC Recommendations on Booster and Additional Dose

[Signed by Secretary of Health] HTAC Interim Recommendations on Pediatric Vaccination for 2022 COVID-19 Vaccine Implementation

[SIGNED BY SECRETARY OF HEALTH] September Updates on 2021 HTAC Recommendations for Rapid Antigen Tests

[Department Circular No. 2021- 0423] Inclusion of Dolutegravir (DTG) in the Philippine National Formulary (PNF)

[Signed by Secretary of Health] letter of Endorsement for Dolutegravir for the second-line treatment for treatment experienced adolescents and auletes living with HIV

[Department Circular No. 2021- 0410] Inclusion of Two-Dose Inactivated Polio Vaccine (IPV) in the Philippine National Formulary (PNF)

[Department Circular No. 2021- 0400] Inclusion of Tenofovir/Lamivudine/Dolutegravir (TLD) in the Philippine National Formulary (PNF)